The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(E)-N-(4-((2-Fluoro-3-(4-methylpiperazin-1-yl)-11-oxo-7,8,9,11-tetrahydro-6H-pyrido[2,1-b]quinazolin-6-ylidene)methyl)phenyl)-3-(4-(2-hydroxyethyl)piperazin-1-yl)propanamide ID: ALA4092023
PubChem CID: 137656263
Max Phase: Preclinical
Molecular Formula: C33H42FN7O3
Molecular Weight: 603.74
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CN1CCN(c2cc3nc4n(c(=O)c3cc2F)CCC/C4=C\c2ccc(NC(=O)CCN3CCN(CCO)CC3)cc2)CC1
Standard InChI: InChI=1S/C33H42FN7O3/c1-37-11-17-40(18-12-37)30-23-29-27(22-28(30)34)33(44)41-9-2-3-25(32(41)36-29)21-24-4-6-26(7-5-24)35-31(43)8-10-38-13-15-39(16-14-38)19-20-42/h4-7,21-23,42H,2-3,8-20H2,1H3,(H,35,43)/b25-21+
Standard InChI Key: CVBQNKILCDFECY-NJNXFGOHSA-N
Molfile:
RDKit 2D
44 49 0 0 0 0 0 0 0 0999 V2000
32.6535 -8.3632 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3598 -8.7908 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.0848 -8.3936 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6723 -7.5385 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.9284 -8.7604 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.7869 -8.8212 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.7723 -9.6460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.4744 -10.0736 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.1994 -9.6764 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.2183 -8.8516 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.5121 -8.4240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.9057 -10.1081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.6267 -9.7109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.3329 -10.1385 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.2263 -8.3329 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5012 -8.7300 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7949 -8.3025 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8138 -7.4777 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5389 -7.0805 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2409 -7.5081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1075 -7.0501 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.6992 -6.1949 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.4201 -5.7936 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4389 -4.9688 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.7327 -4.5453 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0118 -4.9383 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3055 -4.5107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5804 -4.9079 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5658 -5.7327 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2678 -6.1603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9929 -5.7631 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1264 -6.2253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8514 -5.8281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8662 -5.0033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1641 -4.5716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.7516 -3.7206 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.8406 -6.1299 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.8218 -6.9547 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1009 -7.3519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3946 -6.9243 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.4134 -6.0995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1344 -5.7023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6695 -7.3215 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8783 -4.4803 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
1 4 2 0
1 5 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
6 11 1 0
12 13 1 0
13 14 1 0
9 12 1 0
3 6 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
15 20 2 0
22 23 2 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 28 2 0
28 29 1 0
29 30 2 0
30 31 1 0
22 31 1 0
26 31 2 0
32 33 1 0
33 34 1 0
34 35 1 0
23 32 1 0
24 35 1 0
25 36 2 0
37 38 1 0
38 39 1 0
39 40 1 0
40 41 1 0
41 42 1 0
37 42 1 0
40 43 1 0
29 37 1 0
28 44 1 0
21 32 2 0
18 21 1 0
5 15 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 603.74Molecular Weight (Monoisotopic): 603.3333AlogP: 2.56#Rotatable Bonds: 8Polar Surface Area: 97.18Molecular Species: NEUTRALHBA: 9HBD: 2#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 7.97CX LogP: 2.34CX LogD: 1.54Aromatic Rings: 3Heavy Atoms: 44QED Weighted: 0.41Np Likeness Score: -1.23
References 1. Shan C, Yan JW, Wang YQ, Che T, Huang ZL, Chen AC, Yao PF, Tan JH, Li D, Ou TM, Gu LQ, Huang ZS.. (2017) Design, Synthesis, and Evaluation of Isaindigotone Derivatives To Downregulate c-myc Transcription via Disrupting the Interaction of NM23-H2 with G-Quadruplex., 60 (4): [PMID:28128954 ] [10.1021/acs.jmedchem.6b01218 ]